Laxminarayan Ramanan, Mills Anne J, Breman Joel G, Measham Anthony R, Alleyne George, Claeson Mariam, Jha Prabhat, Musgrove Philip, Chow Jeffrey, Shahid-Salles Sonbol, Jamison Dean T
Resources for the Future, 1616 P Street NW Suite 600, Washington, DC 20036, USA.
Lancet. 2006 Apr 8;367(9517):1193-208. doi: 10.1016/S0140-6736(06)68440-7.
The Disease Control Priorities Project (DCPP), a joint project of the Fogarty International Center of the US National Institutes of Health, the WHO, and The World Bank, was launched in 2001 to identify policy changes and intervention strategies for the health problems of low-income and middle-income countries. Nearly 500 experts worldwide compiled and reviewed the scientific research on a broad range of diseases and conditions, the results of which are published this week. A major product of DCPP, Disease Control Priorities in Developing Countries, 2nd edition (DCP2), focuses on the assessment of the cost-effectiveness of health-improving strategies (or interventions) for the conditions responsible for the greatest burden of disease. DCP2 also examines crosscutting issues crucial to the delivery of quality health services, including the organisation, financial support, and capacity of health systems. Here, we summarise the key messages of the project.
疾病控制优先项目（DCPP）是美国国立卫生研究院福格蒂国际中心、世界卫生组织和世界银行的一个联合项目，于2001年启动，旨在确定针对低收入和中等收入国家健康问题的政策变革和干预策略。全球近500名专家收集并审查了关于广泛疾病和健康状况的科研成果，其结果于本周发表。DCPP的一个主要成果《发展中国家的疾病控制重点》第二版（DCP2），重点评估了改善健康策略（或干预措施）对造成最大疾病负担的状况的成本效益。DCP2还审视了对提供高质量卫生服务至关重要的贯穿各领域的问题，包括卫生系统的组织、财政支持和能力。在此，我们总结该项目的关键信息。
